Long-Term Impact of Diabetic Retinopathy on Response to Anti-VEGF Treatment in Neovascular AMD.

27 Importantly, we did not observe any significant differences in MNV flow between the two groups, although the Not Diabetic group exhibited a decreasing trend 12 months post-treatment.

also in 47,180 other papers

This last result appears to be highly significant, especially considering that the size of MNV evaluated with OCTA serves as a valuable biomarker in assessing the response or lack of response to treatment. 25 , 26 The lack of significant reduction of the neovascular membrane area in the Diabetic group after 1 year of treatment suggests a distinct treatment response compared to the continuous reduction observed in the Not Diabetic group.

also in 132,142 other papers